AzTrials
AzTrials

Ultrasound LipolysisNCT06658639

Ultrasound Lipolysis Versus Cryolipolysis On Lipid Profile Levels In Centrally Obese Middle Aged Men

A study testing Ultrasound lipolysis, Cryolipolysis and Low Caloric Diet in people with Ultrasound Lipolysis and Cryolipolysis, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The study compares the effects of ultrasound lipolysis and cryo lipolysis on cholesterol, triglyceride, high density lipoprotein, low density lipoprotein, body mass index, skin thickness, waist circumference, and waist hip ratio in centrally obese middle aged men. Read more about this study

Who is it for?
Ages 40 to 60 years, men only
Conditions the study is for
Ultrasound Lipolysis, Cryolipolysis, Lipid Profile
What is being tested?
Ultrasound lipolysis, Cryolipolysis and Low Caloric Diet
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
66 participants
Where
1 siteEgypt
Study dates
5 Nov 2024to 5 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 60 years
  • Men only
  • No healthy volunteers
  • Adult

Who may be able to join

  • Obese men with middle age range will be 40-60 years.
  • Obese men with central obesity.
  • Body mass index (BMI) greater than 30 Kg \m2.
  • Waist circumference will be >94 cm.
  • Waist to hip ratio more than 0.9

Who cannot join

  • Chronic respiratory disorders and cardiovascular problems.
  • Diabetic patients.
  • Presence of skin diseases in abdominal regions that prevent the use of ultra sound or cryolipolysis therapy.
  • Men with kidney or liver diseases.
  • Tumor diseases
  • Lesions of higher center leading to obesity.
  • History of active or chronic infectious, autoimmune disease.
  • History of abdominal surgeries.

Trial locations and contacts

1 site in 1 country.

Mustafa awad Ali, physical therapist contact

01050366830

mustafaawad279@gmail.com

Egypt1 site
  • out-patient clinic, faculty of physical therapy, Cairo university

    Giza

    Mustafa Awaf Ali, assistant lecturer, 01050366830, mustafaawad279@gmail.com

Other trials in Egypt

About this study

The study compares the effects of ultrasound lipolysis and cryo lipolysis on cholesterol, triglyceride, high density lipoprotein, low density lipoprotein, body mass index, skin thickness, waist circumference, and waist hip ratio in centrally obese middle aged men. It also investigates the impact of ultrasound lipolysis on skin thickness, waist circumference, and waist hip ratio.

Read the detailed description

Obesity has become a key risk factor for the development of cardiovascular diseases and dyslipidemia. Overweight and abdominal obesity has increased in men more than in women.

For young individuals, intra-abdominal fat is the important component of the body fat for six of the eight metabolic risk factors. Intra-abdominal fat might contribute to that most patients with acute myocardial infarction at a young age are men.

Abdominal lipolysis by ultra sonic is a safe and efficacious method and can effectively decrease waist circumference, waist hip ratio and blood cholesterol.

Adding cryolipolysis to a low-calorie diet is protocol from other methods to improve the body profile, in form of body mass index, waist-to-hip ratio, as well subcutaneous fat tissues thickness, but also leads to improvement in lipid profile and liver enzymes

Being tested
Ultrasound lipolysis, Cryolipolysis, Low Caloric Diet
Medical subject headings
Obesity, Abdominal

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound lipolysisDevice

    Ultrasound lipolysis uses a Luvitra device to emit low-frequency ultrasound pulsed waves. The abdominal area is divided into two sections and the patient is placed in a comfortable supine lying position. The cavitation head is applied slowly to each segment in small circular movements. The treatment lasts 30 minutes on each side, with each session lasting 60 minutes. The same abdominal area is treated every two weeks for three months. The procedure involves cleaning the skin with alcohol cotton.

  • CryolipolysisDevice

    The study utilized Lipocool, a cryolipolysis apparatus from Korea, with a thermoelectric cooling element. Participants were treated with thermal coupling gel on their abdomen, and the tissue was drawn into the applicator with a moderate vacuum. The device was used for 40-50 minutes, with energy extraction controlled by sensors. The system stopped cold exposure and the clinician released the vacuum. Participants underwent cryolipolysis sessions every 2 weeks for 3 months.

  • Low Caloric DietOther

    A low-calorie diet is a structured plan that restricts daily caloric intake, often used for weight loss. It involves consuming 1,200 to 1,500 calories daily, creating a calorie deficit. However, it requires discipline and safety. The diet is low in fat (20-25%), high in complex carbohydrates (60%), and sufficient in protein (25-50%).

Study groups in NCT06658639
Study groupRoleWhat they receive
ultrasound lipolysis groupExperimentalit involves 22 participants and will receive ultrasound lipolysis on abdominal area and low caloric diet treatment. abdominal area was treated for 60-minute session every 2 weeks for 3 months
Receives: Device: Ultrasound lipolysis; Other: Low Caloric Diet
cryolipolysis groupActive comparatorit involves 22 participants and will receive cryolipolysis on abdominal area and low caloric diet treatment. Each participant underwent a cryolipolysis session on the same abdominal area every 2 weeks for 3 months
Receives: Device: Cryolipolysis; Other: Low Caloric Diet
low caloric diet groupActive comparatorit involves 22 participants and will receive low caloric diet treatment for 3 months.
Receives: Other: Low Caloric Diet

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. assessment of change of lipid profile

    A low-calorie diet is a structured plan that restricts daily caloric intake, often used for weight loss. It involves consuming 1,200 to 1,500 calories daily, creating a calorie deficit. However, it requires discipline and safety. The diet is low in fat (20-25%), high in complex carbohydrates (60%), and sufficient in protein (25-50%).

    Measured: at baseline and after 3 months

Secondary outcomes (4)
  1. assessment of BMI using Body weight and height scale

    For measuring weight in kg and height in cm to calculate the body mass index (BMI) by dividing weight in kg on Height in meter square

    Measured: at baseline and after 3 months

  2. assessment of change of skin fold thickness using skin caliper

    A caliper is used to measure suprailiac skinfold thickness where subcutaneous fat is pulled away from the muscle with the caliper tongs situated at their ends. For men, the direction of fold pulling was vertical and is taken 2 cm to the side of the umbilicus.

    Measured: at baseline and after 3 months

  3. assessment of change of Waist Circumference using tape measurement

    A tape, resistant to stretching will be used to measure the waist circumference at the midpoint in line between the lower border of the last felt rib and the iliac crest's highest point. All patients will standing in a comfortable position, with both feet in close proximity, both arms beside the body

    Measured: at baseline and after 3 months

  4. assessment of change of Waist Hip Ratio

    Using a non-stretchable tape, the hips is measured at the widest part of the hip bones, and the waist is measured at the midpoint in line between the lower border of the last felt rib and the iliac crest's highest point then the WHR will calculated by dividing the waist measurement by the hip measurement.

    Measured: at baseline and after 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2024
  2. Study start5 Nov 2024 (estimated)
  3. Primary completion5 Mar 2025 (estimated)
  4. Study completion5 Apr 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
66 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06658639
Sponsor's protocol ID
Mustafa-004363
Status last verified
Oct 2024
First submitted
24 Oct 2024
Last updated
26 Oct 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasound lipolysis, Cryolipolysis and Low Caloric Diet in people with Ultrasound Lipolysis and Cryolipolysis, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Mustafa awad Ali, physical therapist (01050366830, mustafaawad279@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

assessment of change of lipid profile (time frame: at baseline and after 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in